Schrodinger(SDGR) - 2024 Q4 - Earnings Call Presentation

Revolutionizing Medicines and Materials Discovery 4Q/FY24 Financial Results February 26, 2025 Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, made by Schrödinger, Inc. ("we," "us," "our," "Schrödinger," or the "Company") contained in this presentation, including, without limit ...